Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03738579 · ClinicalTrials.gov registry record · NA
Evaluating Wound Healing With Next Science Gel & Wash.
A NA study, sponsored by Next Science TM.
- Terminated
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT03738579: Clinical Trial NA study, sponsored by Next Science TM.
NCT03738579 is a NA study that was terminated before completion, run by Next Science TM. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03738579, a NA study, was terminated before completion, sponsored by Next Science TM.
- TERMINATED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
This is a 12-week, single-site, open-label prospective study in adult with a chronic wound diagnosis. Subjects will be randomized in equal numbers to either the control treatment arm, antimicrobial control treatment arm, or Next Science treatment arm and will receive this treatment until the wound is completely healed or they are exited from the study. Subjects will have a weekly in-office debridement visit for up to 12 weeks.
Primary Outcome
Significantly Reduced Wound Size and Volume (measured using Aranz Aranz Medical Silhouette Imaging System) at One or More of the Measured Time Points with Next Science Group compared to Control Group(s)
Interventions
- DEVICE Control Group
- DEVICE Next Science Group
- DEVICE Antibacterial Control Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-10-17 |
| Est. Completion | 2019-06-25 |
| Phase | NA |
Why NCT03738579 stopped before completion
NCT03738579 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which Control Group is the first listed.
NCT03738579 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03738579 about?
NCT03738579 is a clinical study titled "Evaluating Wound Healing With Next Science Gel & Wash.". This is a 12-week, single-site, open-label prospective study in adult with a chronic wound diagnosis. Subjects will be randomized in equal numbers to either the control treatment arm, antimicrobial control treatment arm, or Next Science treatment arm and will receive this treatment until the wound i...
What is the current status of trial NCT03738579?
This trial is currently terminated. It is a NA study. The enrollment target is 10 participants. The study started on 2018-10-17. Estimated completion is 2019-06-25.
What interventions are being tested in trial NCT03738579?
The interventions under investigation include: Control Group (DEVICE), Next Science Group (DEVICE), Antibacterial Control Group (DEVICE).
Who is sponsoring clinical trial NCT03738579?
This trial is sponsored by Next Science TM, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03738579's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI